Selective Alfa-1-adrenergic Blocking Agents

Name
Selective Alfa-1-adrenergic Blocking Agents
Accession Number
DBCAT003670
Description

Not Available

Drugs
DrugDrug Description
AlfuzosinAn alpha-1 adrenergic antagonist used in the symptomatic management of benign prostatic hypertrophy (BPH).
TamsulosinAn alpha-1A and alpha-1B adrenergic receptor antagonist used to treat benign prostatic hyperplasia, ureteral stones, prostatitis, and female voiding dysfunction.
SilodosinAn alpha-1 adrenergic receptor antagonist used to treat symptoms associated with benign prostatic hyperplasia (BPH).
Drugs & Drug Targets
DrugTargetType
AlfuzosinAlpha-1A adrenergic receptortarget
AlfuzosinAlpha-1B adrenergic receptortarget
AlfuzosinAlpha-1D adrenergic receptortarget
AlfuzosinCytochrome P450 3A4enzyme
AlfuzosinP-glycoprotein 1transporter
AlfuzosinAlpha-1 adrenergic receptorstarget
AlfuzosinSerum albumincarrier
AlfuzosinAlpha-1-acid glycoprotein 1carrier
TamsulosinAlpha-1A adrenergic receptortarget
TamsulosinAlpha-1D adrenergic receptortarget
TamsulosinAlpha-1B adrenergic receptortarget
TamsulosinAlpha-1-acid glycoprotein 1carrier
TamsulosinCytochrome P450 2D6enzyme
TamsulosinCytochrome P450 3A4enzyme
SilodosinAlpha-1D adrenergic receptortarget
SilodosinCytochrome P450 3A4enzyme
SilodosinP-glycoprotein 1transporter
SilodosinMultidrug resistance protein 3transporter
SilodosinAlpha-1A adrenergic receptortarget
SilodosinAlpha-1B adrenergic receptortarget
SilodosinUDP-glucuronosyltransferase 2B7enzyme
SilodosinAldehyde dehydrogenase, mitochondrialenzyme
SilodosinAlcohol dehydrogenase [NADP(+)]enzyme
SilodosinHERG human cardiac K+ channeltarget